Growth Metrics

Bristol Myers Squibb (BMYMP) Short-term Investments (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Short-term Investments for 17 consecutive years, with $464.0 million as the latest value for Q4 2025.

  • Quarterly Short-term Investments fell 9.55% to $464.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $464.0 million through Dec 2025, down 9.55% year-over-year, with the annual reading at $464.0 million for FY2025, 9.55% down from the prior year.
  • Short-term Investments for Q4 2025 was $464.0 million at Bristol Myers Squibb, down from $776.0 million in the prior quarter.
  • The five-year high for Short-term Investments was $3.0 billion in Q4 2021, with the low at $130.0 million in Q4 2022.
  • Average Short-term Investments over 5 years is $1.1 billion, with a median of $796.0 million recorded in 2023.
  • The sharpest move saw Short-term Investments tumbled 95.65% in 2022, then soared 527.69% in 2023.
  • Over 5 years, Short-term Investments stood at $3.0 billion in 2021, then crashed by 95.65% to $130.0 million in 2022, then skyrocketed by 527.69% to $816.0 million in 2023, then tumbled by 37.13% to $513.0 million in 2024, then fell by 9.55% to $464.0 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $464.0 million, $776.0 million, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.